Protein kinase C-theta;: signaling from the center of the T-cell synapse

Christopher W Arendt1, Björn Albrecht, Timothy J Soos

  • 1Howard Hughes Medical Institute and Molecular Pathogenesis Program, Skirball Institute of Biomolecular Medicine, New York University School of Medicine, 540 First Avenue, New York, NY 10016, USA.

Insights

Protein kinase C-theta (PKC-theta) is crucial for T-lymphocyte activation. Mice lacking PKC-theta showed impaired NF-kappaB, AP-1 activation, and IL-2 expression upon TCR stimulation, confirming its role.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Signaling

Background:

  • Protein kinase C-theta (PKC-theta) is implicated in T-cell activation based on cell line studies.
  • The precise role of PKC-theta in T-lymphocyte signaling pathways requires further elucidation.

Purpose of the Study:

  • To confirm the role of PKC-theta in T-lymphocyte activation using knockout mice.
  • To investigate the downstream signaling events affected by the absence of PKC-theta.

Main Methods:

  • Utilized genetically modified mice lacking PKC-theta expression.
  • Stimulated peripheral T cells with T-cell receptor (TCR) agonists.
  • Assessed the activation of transcription factors NF-kappaB and AP-1.
  • Quantified the expression of Interleukin-2 (IL-2).

Main Results:

  • T cells from PKC-theta-deficient mice failed to activate NF-kappaB and AP-1 in response to TCR stimulation.
  • IL-2 expression was significantly reduced in T cells lacking PKC-theta.
  • These findings highlight PKC-theta's critical role in linking early signaling events to transcriptional responses.

Conclusions:

  • PKC-theta is essential for T-lymphocyte activation, specifically for the induction of NF-kappaB, AP-1, and IL-2.
  • The enzyme acts as a key mediator connecting membrane-proximal signaling to T-cell transcriptional programs.
  • Further research into PKC-theta's molecular interactions will refine models of T-cell activation.

Related Concept Videos

Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...